Terns Pharmaceuticals said on Tuesday it will stop developing its experimental obesity drug after a mid-stage trial showed modest weight loss and raised safety concerns.

Celcuity expects to complete a rolling NDA submission for gedatolisib under the FDA RTOR program by Q4 2025. Click here to ...

New data from the U.S. Census Bureau makes one thing clear: public programs work. Data from the 2024 Supplemental Poverty ...

A new analysis of publicly available federal data found that, since 2017, the quality of care at these facilities has been ...

A lapse in funding due to the shutdown could have a devastating effect on the millions of Americans who rely on the federal ...

The protest was set to coincide with a Board of Supervisors vote on whether to expand an existing pilot program that ...

Arizona solar EPA cuts Solar for All program opposed by advocates warning of job losses and energy grid strain ...

The funding comes as federal and state budget reductions threaten to pause the statewide research, which could disrupt monitoring Iowa's rivers.

According to new data, 73% of all participants in treatment courts did not commit another felony offense within five years of ...

Texas officials identify over 2,700 possible illegal immigrants registered to vote, sending cases to counties for 30-day ...

Polk County leaders announced a plan to fund water quality monitors in Iowa after state lawmakers cut funding, ensuring the ...

The U.S. Department of Agriculture will not pay out Supplemental Nutrition Assistance Program (SNAP) in November if the ...